First Citizens BancShares Report: AI-Driven Provider Operations Dominate 2025 Healthtech Investments, Surpassing $5.5B

Reuters
2025/10/16
<a href="https://laohu8.com/S/FCNCB">First Citizens BancShares</a> Report: AI-Driven Provider Operations Dominate 2025 Healthtech Investments, Surpassing $5.5B

First Citizens BancShares Inc., through its division Silicon Valley Bank, has released its 2025 Healthtech market analysis, highlighting a surge in venture capital investment in provider operations. According to the report, provider operations-covering activities such as scheduling, documentation, and billing-have attracted $5.5 billion in investment so far this year, with projections reaching $8.25 billion by year-end. This sub-sector now accounts for 44% of overall Healthtech investment, on track to surpass previous records. AI-enabled solutions dominate the sector, comprising 73% of Healthtech mega-deals and 52% of all deals in 2025. The report also notes a 42% increase in seed-stage AI valuations since 2021 and a notable rise in consolidation, with 32 M&A deals recorded in provider operations this year. Generalist investors like Andreessen Horowitz and General Catalyst are driving a 22% valuation premium in mega-deals, which make up 38% of total Healthtech investment. Overall, Healthtech investment is expected to reach $18.5 billion by the end of 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. First Citizens BancShares Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF99485) on October 16, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10